News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,749 Results
Type
Article (40060)
Company Profile (288)
Press Release (665401)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (206557)
Career Advice (2020)
Deals (35735)
Drug Delivery (95)
Drug Development (82118)
Employer Resources (174)
FDA (16220)
Job Trends (14989)
News (349044)
Policy (32735)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2562)
Accelerated approval (5)
Adcomms (20)
Allergies (83)
Alliances (50076)
ALS (89)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (122)
Approvals (16225)
Artificial intelligence (247)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11738)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (205)
Bladder cancer (67)
Brain cancer (27)
Breast cancer (274)
Cancer (2176)
Cardiovascular disease (174)
Career advice (1685)
Career pathing (30)
CAR-T (145)
Cell therapy (408)
Cervical cancer (19)
Clinical research (66796)
Collaboration (825)
Compensation (526)
Complete response letters (19)
COVID-19 (2595)
CRISPR (37)
C-suite (236)
Cystic fibrosis (101)
Data (2106)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (263)
Diagnostics (6367)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (87391)
Editorial (36)
Employer branding (22)
Employer resources (148)
Events (114244)
Executive appointments (714)
FDA (17436)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (743)
Gene editing (100)
Generative AI (19)
Gene therapy (287)
GLP-1 (712)
Government (4427)
Grass and pollen (5)
Guidances (52)
Healthcare (18860)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (29)
Infectious disease (2737)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (93)
Interviews (315)
IPO (16686)
IRA (40)
Job creations (3676)
Job search strategy (1431)
Kidney cancer (10)
Labor market (38)
Layoffs (466)
Leadership (16)
Legal (7936)
Liver cancer (73)
Lung cancer (311)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (296)
MASH (66)
Medical device (13370)
Medtech (13375)
Mergers & acquisitions (19582)
Metabolic disorders (672)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1902)
NextGen: Class of 2025 (6538)
Non-profit (4492)
Northern California (2605)
Now hiring (39)
Obesity (359)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (21)
Patents (229)
Patient recruitment (106)
Peanut (46)
People (57943)
Pharmaceutical (74)
Pharmacy benefit managers (18)
Phase I (20834)
Phase II (29463)
Phase III (21837)
Pipeline (1139)
Policy (135)
Postmarket research (2569)
Preclinical (8823)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (253)
Rare diseases (374)
Real estate (5998)
Recruiting (66)
Regulatory (22402)
Reports (46)
Research institute (2332)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (68)
Series A (128)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2237)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3621)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (28)
United States (22670)
Vaccines (682)
Venture capitalists (41)
Weight loss (232)
Women's health (35)
Worklife (15)
Date
Last 7 days (643)
Last 30 days (2371)
Last 365 days (32972)
2025 (9933)
2024 (35566)
2023 (40474)
2022 (51632)
2021 (56245)
2020 (54472)
2019 (46906)
2018 (35318)
2017 (32509)
2016 (31952)
2015 (38017)
2014 (31844)
2013 (26768)
2012 (28943)
2011 (29608)
2010 (27675)
Location
Africa (728)
Alabama (57)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (38763)
Australia (6291)
California (5955)
Canada (1975)
China (517)
Colorado (264)
Connecticut (267)
Delaware (140)
Europe (83893)
Florida (889)
Georgia (202)
Idaho (57)
Illinois (522)
India (25)
Indiana (306)
Iowa (11)
Japan (158)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (879)
Massachusetts (4473)
Michigan (216)
Minnesota (386)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1698)
New Mexico (29)
New York (1697)
North Carolina (1001)
North Dakota (7)
Northern California (2605)
Ohio (199)
Oklahoma (14)
Oregon (35)
Pennsylvania (1338)
Puerto Rico (12)
Rhode Island (32)
South America (1109)
South Carolina (22)
South Dakota (1)
Southern California (2237)
Tennessee (101)
Texas (886)
Utah (177)
Virginia (143)
Washington D.C. (62)
Washington State (551)
West Virginia (3)
Wisconsin (52)
705,749 Results for "tlc biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
OrsoBio to Present Phase 1 and Preclinical Data for Liver-Targeted Mitochondrial Protonophore TLC-6740 at the American Diabetes Association’s 84th Scientific Sessions
OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, today announced new data for liver-targeted mitochondrial protonophore TLC-6740 being presented at the 84th Scientific Sessions of the American Diabetes Association being held June 21-24, 2024, in Orlando, Fla.
June 21, 2024
·
6 min read
Drug Development
TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR
TLC BioSciences announced that the Abstract Selection Committee of the American College of Rheumatology has accepted TLC’s late-breaking abstract on TLC599 for oral presentation at ACR Convergence 2023.
November 8, 2023
·
4 min read
Biotech Bay
TLC to Present at the 42nd Annual JP Morgan Healthcare Conference
TLC BioSciences announced that the company will present at the 42nd Annual JP Morgan Healthcare Conference at 2:00pm PT on Tuesday, January 9, 2024.
December 27, 2023
·
1 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Drug Development
OrsoBio to Present Phase 1 Data for the Liver-Targeted Mitochondrial Protonophore TLC-6740 in Development for the Treatment of Obesity at ObesityWeek® 2023
OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced preliminary safety and pharmacokinetic (PK) data from the single ascending dose (SAD) portion of an ongoing Phase 1 trial of TLC-6740, a liver-targeted, mitochondrial protonophore.
October 16, 2023
·
5 min read
Drug Development
OrsoBio Announces Phase 1 Trial of TLC-6740, a Mitochondrial Protonophore for the Treatment of Obesity and Associated Diseases
OrsoBio, Inc. today announced completion of the second cohort of subjects in an ongoing Phase 1 trial of TLC-6740, a liver-targeted mitochondrial protonophore.
June 5, 2023
·
4 min read
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
BioMidwest
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will be hosting a virtual meeting of its stockholders at 1pm ET on Monday, July 8th, 2024.
June 20, 2024
·
5 min read
Drug Development
OrsoBio Announces First Patient Dosed in Phase 2 Clinical Trial of the ACC2 Inhibitor TLC-3595, a Potential Treatment for Type 2 Diabetes
OrsoBio, Inc. today announced that the first patient has been dosed in a Phase 2a clinical trial evaluating TLC-3595, a selective inhibitor of acetyl-CoA carboxylase 2 (ACC2).
March 20, 2023
·
4 min read
Press Releases
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 2, 2025
·
2 min read
1 of 70,575
Next
